Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Teen Success Project (JPO-CM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03015805
Recruitment Status : Recruiting
First Posted : January 10, 2017
Last Update Posted : March 3, 2020
Sponsor:
Collaborator:
George Mason University
Information provided by (Responsible Party):
Ashli Sheidow, Oregon Social Learning Center

Tracking Information
First Submitted Date  ICMJE January 6, 2017
First Posted Date  ICMJE January 10, 2017
Last Update Posted Date March 3, 2020
Actual Study Start Date  ICMJE October 1, 2017
Estimated Primary Completion Date June 2021   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: January 6, 2017)
  • Changes from Baseline scores compared to 9 months post-Baseline Urine Drug Screens (measured at 0, 3, 6 and 9 months). [ Time Frame: Baseline to 9 months ]
    The number of positive drug screens from toxicology testing for tetrahydrocannabinol (THC), synthetic THC, amphetamines, methamphetamines, opiates, phencyclidine (PCP), cocaine, benzodiazepines and alcohol metabolites (Ethyl glucuronide, Ethyl sulfate ).
  • Changes from Baseline scores compared to 9 months post-Baseline Substance Use and Problems (measured at 0, 3, 6 and 9 months). [ Time Frame: Baseline to 9 months ]
    Frequency of substance use and substance-related problems self-reported on the Global Appraisal of Individual Needs.
Original Primary Outcome Measures  ICMJE Same as current
Change History
Current Secondary Outcome Measures  ICMJE
 (submitted: January 6, 2017)
  • Changes in number and severity of criminal charges in official records in the 18 months pre-Baseline compared with 18 months post-Baseline. [ Time Frame: 18 months pre-Baseline to 18 months post-Baseline. ]
    Changes from 18 months pre-Baseline in offending, measured in the number and severity of offenses in official arrest records compared to 18 months post-Baseline.
  • Changes from Baseline scores compared to 9 months post-Baseline Delinquent Behaviors (measured at 0, 3, 6 and 9 months). [ Time Frame: Baseline to 9 months. ]
    Delinquent behaviors self-reported using the Self-Report Delinquency Scale.
  • Changes from Baseline scores compared to 9 months post-Baseline Sexual Risk Behaviors (measured at 0, 3, 6 and 9 months). [ Time Frame: Baseline to 9 months. ]
    Sexual risk behaviors self-reported using the HIV Sexual Risk Behavior Scale.
  • Changes from Baseline scores compared to 9 months post-BaselineTreatment Usage (measured at 0, 3, 6 and 9 months). [ Time Frame: Baseline to 9 months. ]
    The number of courses of in-patient and out-patient treatment obtained by youth for substance abuse as measured by the Structured Adolescent Interview (conducted with youth and caregiver together).
  • Changes from Baseline scores compared to 9 months post-Baseline Internalizing and Externalizing Behaviors (measured at 0, 3, 6 and 9 months). [ Time Frame: Baseline to 9 months. ]
    The frequency of youth's internalizing and externalizing behaviors as measured using the Brief Problem Checklist (self- and parent-report).
  • Changes from Baseline scores compared to 31 months post-Baseline Contingency Management (CM) Adherence (measured monthly for 31 months). [ Time Frame: Baseline to 31 months. ]
    Adherence to CM practices by juvenile probation officers as measured using the CM-Therapist Adherence Measure (CM-TAM) (Self-report version, Tape Coding version and Youth/Caregiver versions).
  • Changes from Baseline in Training Needs and Training Satisfaction scores compared to 31 months post-Baseline (measured at 0,16 and 31 months). [ Time Frame: Baseline to 31 months. ]
    Scores in training needs and training satisfaction as measured by the Organizational Readiness for Change-Criminal Justice Version (completed by participating juvenile probation officers).
  • Changes from Baseline in attitudes towards using rewards in substance abuse treatment compared to 31 months post-Baseline (measured at 0,16 and 31 months). [ Time Frame: Baseline to 31 months. ]
    Ratings on attitudes towards using rewards in substance use treatment as measured by the Provider Survey of Incentives (completed by participating juvenile probation officers).
  • Changes from Baseline in attitudes towards Contingency Management (CM) compared to 31 months post-Baseline (measured at 0,16 and 31 months). [ Time Frame: Baseline to 31 months. ]
    Ratings on attitudes towards Contingency Management as measured by qualitative ratings of audio-taped and transcribed focus groups (focus groups involve participating juvenile probation officers).
Original Secondary Outcome Measures  ICMJE Same as current
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE Teen Success Project
Official Title  ICMJE Improving Access to Substance Abuse Evidence-Based Practices for Youth in the Justice System: Strategies Used by JPOs
Brief Summary The purpose of this study is to examine the effectiveness of Juvenile Probation Officers (JPOs) delivering Contingency Management (CM) to teens on their caseload who have problems with drug use. CM has already been shown to be effective at helping teens with drug problems but CM has never been delivered by JPOs. This study will test how well it works to have JPOs deliver CM during their regular meetings with teens.
Detailed Description The overarching purpose of this study is to increase justice-involved youths' access to an evidence-based practice for substance abuse, specifically Contingency Management (CM). This randomized controlled trial will examine the effectiveness of using juvenile probation officers (JPOs) to deliver CM to youth (aged 12-17 years) on their caseloads. CM is an evidence-based practice for substance abuse. The Investigators posit that JPOs are in an ideal position to deliver an evidence-based practice such as CM to youth because of their intensive involvement and frequent contact with the youth offenders under their supervision. The study randomizes 36 JPOs to 2 conditions: CM versus control (usual JPO services), and then randomizes 504 drug-abusing adolescent probationers across those 2 conditions. The research team will work with JPOs employed by the Department of Youth Services (DYS) in various counties in Oregon. JPOs will participate in focus groups and research interviews and will submit monthly audio-tapes of sessions with participating youth. JPOs randomized to the CM condition will receive training in how to deliver CM. As stated, participating youth will also be randomized to CM or control and assigned to a JPO in the same condition. For those in the CM group, the delivery of CM will be added to their regular meetings with their JPO. Research data will be collected from families via audio-taped interviews and questionnaires from youth and one caretaker. Urine samples for drug testing will also be collected from youth. Lastly, arrest records will be collected on youth for the 18 months pre- and post-entry into the study. The study involves 2 types of participants: youth (n=504) and juvenile probation officers (n=36), for a total of 540 anticipated participants.
Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Condition  ICMJE Substance Abuse
Intervention  ICMJE
  • Behavioral: Contingency Management
    Contingency Management (CM) utilizes behavior modification & cognitive behavioral strategies to target adolescent alcohol or other drug (AOD) use. Protocol components are as follows: (a) The provider introduces CM to the family and engages them in the intervention; (b) The provider conducts Antecedent-Behavior-Consequence (ABC) assessments of the youth's AOD use with the youth and caregiver; (c) Based on the results of the ABC assessments, self-management planning and drug refusal skills training are implemented by the provider in collaboration with the caregiver; (d) Concurrently, a point and level system contract is filled in by the family, which provides rewards/privileges for negative drug and alcohol tests and disincentives (e.g., extra chores) for positive tests. Until continued abstinence is achieved, components "b" through "d" are repeated; (e) The provider collaborates with the family to develop plans for sustaining long-term abstinence. Typical duration of CM is 12-16 weeks.
  • Behavioral: Probation as Usual
    Standard services that a young person would receive while under probation supervision in the state of Oregon.
Study Arms  ICMJE
  • Experimental: Contingency Management
    This group will receive regular probation services but will also receive the Contingency Management program for substance abuse from their juvenile probation officer during regular meetings.
    Intervention: Behavioral: Contingency Management
  • Active Comparator: Probation as Usual
    This group will receive regular services that are usually provided by juvenile probation officers.
    Intervention: Behavioral: Probation as Usual
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Recruiting
Estimated Enrollment  ICMJE
 (submitted: January 6, 2017)
540
Original Estimated Enrollment  ICMJE Same as current
Estimated Study Completion Date  ICMJE February 2022
Estimated Primary Completion Date June 2021   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

There are 2 types of participants in this study: youth and juvenile probation officers.

Inclusion Criteria for youth:

  • Newly opened probation case (can have previous cases)
  • 12-17 years old
  • Diagnostic and Statistical Manual-5 (DSM-5) substance use disorder

Exclusion Criteria for youth:

  • Pervasive developmental disorder
  • Active psychotic disorder
  • Severe/profound mental retardation

Inclusion Criteria for juvenile probation officers:

  • Employed as a juvenile probation officer with the Department of Youth Services in a participating county in Oregon
  • Serving clients aged 12-17 years old with a substance abuse problem

Exclusion Criteria for juvenile probation officers:

  • Not employed as a juvenile probation officer with the Department of Youth Services in a participating county in Oregon
  • Not serving clients aged 12-17 years old with a substance abuse problem
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 12 Years to 17 Years   (Child)
Accepts Healthy Volunteers  ICMJE No
Contacts  ICMJE
Contact: Ashli Sheidow, Ph.D. 541-485-2711 AshliS@oslc.org
Contact: Michael McCart, Ph.D. 541-485-2711 MikeM@oslc.org
Listed Location Countries  ICMJE United States
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT03015805
Other Study ID Numbers  ICMJE R01DA041434-01( U.S. NIH Grant/Contract )
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement  ICMJE
Plan to Share IPD: No
Responsible Party Ashli Sheidow, Oregon Social Learning Center
Study Sponsor  ICMJE Oregon Social Learning Center
Collaborators  ICMJE George Mason University
Investigators  ICMJE Not Provided
PRS Account Oregon Social Learning Center
Verification Date March 2020

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP